| Application no. and date | 15711523.9 (espacenet) (Federated) (European Patent Register), 20150324 | | Patent/reg. no. and date | DK/EP 3122378, 20191211 | | Publication date | 20170201 | | Priority no. and date | EP 14161861, 20140326, EP 14192913, 20141112 | | EP pub. no. and date |
EP 3122378 20170201 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals S.A., Rue de l'Institut, 89
1330 Rixensart, BE | | Applicant ref. no. | 163276 | | Inventor | BAGNOLI, Fabio, GlaxoSmithKline
Via Fiorentina 1
I-53100 Siena, IT,
FIASCHI, Luigi, GlaxoSmithKline
Via Fiorentina 1
I-53100 Siena, IT,
SCARSELLI, Maria, GlaxoSmithKline
Via Fiorentina 1
I-53100 Siena, IT | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 35/74 (2015.01) , A61K 39/00 (2006.01) , A61K 39/085 (2006.01) , A61K 39/39 (2006.01) , C07K 14/31 (2006.01) | | Title | Mutante stafylokokantigener | | Int. application no. | EP2015056175 | | Int. publication no. | WO2015144653 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
